Home › ABL Successfully Completes Drug Product Manufacture Of Ebola Vaccine For Clinical Trial
 

Keywords :   


ABL Successfully Completes Drug Product Manufacture Of Ebola Vaccine For Clinical Trial

2015-07-01 08:22:45| drugdiscoveryonline Home Page

ABL, Inc. (ABL), a contract research and manufacturing organization to the biopharmaceutical industry, is pleased to announce the successful aseptic formulation and fill of an Ebola vaccine candidate for Emergent BioSolutions Inc. (EMERGENT)

Tags: product trial drug successfully

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11S
24.11
24.115
24.11SR
24.11 RC24.4.5
24.11115+128717dz
24.11lavaSUKALA 3
24.11508A
More »